(Q36084052)

12 August 2017

1 reference

title

Testosterone therapy--what, when and to whom? (English)

1 reference

12 August 2017

1 reference

1 reference

Jockenhövel F

1

1 reference

12 August 2017

language of work or name

1 reference

1 December 2004

1 reference

12 August 2017

1 reference

12 August 2017

volume

7

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

319-324

1 reference

Andropause (or symptomatic late-onset hypogonadism): facts, fiction and controversies

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13685530400016557

Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530400016557

Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International Society for the Study of the Aging Male

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530400016557

A new oral testosterone undecanoate formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530400016557

Oral testosterone undecanoate (Andriol) supplement therapy improves the quality of life for men with testosterone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530400016557

Experience with transdermal testosterone replacement therapy for hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530400016557

10.1080/13685530400016557

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference